Claims for Patent: 4,735,898

Summary for Patent: 4,735,898

Title:	Monoclonal antibodies and method of identifying species using the same
Abstract:	The new method an products recognize human serum albumin, differentiating blood and tissue from human sources from blood and tissue of other animals. The method and products are particularly useful in forensic investigations. First, mice are injected with purified human serum albumin, spleen cells from the mice are fused with cells from a murine myeloma. Resulting hyberdomas are screened on human serum albumin coated plates. Subcloning, stabilizing by culture and continued assays for anti-human albumin activity produces products which recognize and differentiate blood or tissue samples from samples of other species.
Inventor(s):	Herr; John C. (Charlottesville, VA), Benjamin; David C. (Charlottesville, VA)
Assignee:	The University of Virginia Alumini Patents Foundation (Charlottesville, VA)
Application Number:	06/755,564
Patent Claims:	1. Hybrid cell line ATCC No. 8860 secreting monoclonal antibodies specifically reactive with human serum albumin. 2. Monoclonal antibodies secreted by the hybrid cell line of claim 1. 3. A method of identification of species of origin of blood, bloodstain, or tissue sample comprising contacting a sample containing albumin with anti-albumin monoclonal antibodies specific to a particular species and sensing reactivity of the monoclonal antibody with the albumin from the sample. 4. The method of claim 3 wherein the albumin is from the human species and wherein the contacting comprises contacting the albumin with human anti-albumin. 5. The method of claim 4 further comprising the preliminary steps of preparing the sample by isolating albumin from the sample. 6. The method of claim 4 comprising placing the monoclonal antibodies on a plate means and adding the sample to the substrate. 7. The method of claim 5 further comprising placing the albumin from the sample on the plate means and adding the monoclonal antibodies to the substrate. 8. The method of claim 4 wherein the sensing reactivity comprises sensing absorption readings which indicate specificity of the monoclonal antibodies for human albumin. 9. A forensic kit for identification of human species of blood, bloodstain, or tissue samples comprising human anti-albumin monoclonal antibodies, plate means for containing the monoclonal antibodies with albumin from a sample, enzyme and substrate for indicating the reactivity of the monoclonal antibodies with albumin from the sample. 10. The method of claim 3 wherein the monoclonal antibody is ATCC No. HB 8860. 11. The kit of claim 9 wherein the monoclonal antibody is ATCC No. HB 8860.

Details for Patent 4,735,898

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Grifols Therapeutics Llc	ALBUKED, PLASBUMIN-20, PLASBUMIN-25, PLASBUMIN-5	albumin (human)	For Injection	101138	10/21/1942		2040-01-28
Baxalta Us Inc.	BUMINATE, FLEXBUMIN	albumin (human)	Injection	101452	03/03/1954		2040-01-28
Csl Behring Ag	ALBURX	albumin (human)	Injection	102366	07/23/1976		2040-01-28
Grifols Biologicals Llc	ALBUTEIN	albumin (human)	Injection	102478	08/15/1978		2040-01-28
Instituto Grifols, S.a.	HUMAN ALBUMIN GRIFOLS	albumin (human)	Injection	103352	02/17/1995		2040-01-28
Instituto Grifols, S.a.	HUMAN ALBUMIN GRIFOLS	albumin (human)	Injection	103352	06/11/2003		2040-01-28